PMID- 24697759 OWN - NLM STAT- MEDLINE DCOM- 20141014 LR - 20140818 IS - 1537-2995 (Electronic) IS - 0041-1132 (Linking) VI - 54 IP - 8 DP - 2014 Aug TI - Infusion technique of hematopoietic progenitor cells and related adverse events (CME). PG - 1997-2003; quiz 1996 LID - 10.1111/trf.12572 [doi] AB - BACKGROUND: The use of hematopoietic progenitor cell (HPC) transplant has risen over the past two decades. A variety of adverse events (AEs) of varying severity have been noted during HPC infusions. These AEs have been associated with several factors such as the amount of dimethyl sulfoxide and white blood cells in the HPC product. We performed a single-institution retrospective analysis to determine the effect of two different HPC infusion techniques, manual push with syringes versus infusion from bags with the aid of gravity, on the occurrence of infusion-related AEs. STUDY DESIGN AND METHODS: Infusions between December 2008 and November 2010 involving peripheral blood HPCs were reviewed. Pertinent clinical and HPC product-related information was recorded. Data were analyzed to determine the incidence of infusion-related AEs and its association with patient and product-related variables. RESULTS: We found 461 AEs in 645 patients during the study period. A total of 325 (50%) experienced at least one AE. Flushing was the most common type of AE followed by nausea and hypertension. The use of syringe infusion was more commonly associated with AEs (odds ratio, 1.82 [95% confidence interval, 1.32-2.50]; p=0.002). Other independent risk factors were cryopreserved products and the amount of polymorphonuclear leukocytes in the product. CONCLUSION: To our knowledge, this is the first study examining the effect of two different infusion techniques on infusion-related AEs. Our findings suggest that the use of bags for infusion protected the patients from AEs. CI - (c) 2014 AABB. FAU - Mulay, Sudhanshu B AU - Mulay SB AD - Division of Hematology/Oncology, University of Connecticut Health Center, Farmington, Connecticut. FAU - Greiner, Carl W AU - Greiner CW FAU - Mohr, Amy AU - Mohr A FAU - Bryant, Sandra C AU - Bryant SC FAU - Lingineni, Ravi K AU - Lingineni RK FAU - Padley, Doug AU - Padley D FAU - Hogan, William J AU - Hogan WJ FAU - Gastineau, Dennis A AU - Gastineau DA FAU - Jacob, Eapen K AU - Jacob EK LA - eng PT - Journal Article DEP - 20140217 PL - United States TA - Transfusion JT - Transfusion JID - 0417360 RN - 0 (Cryoprotective Agents) RN - 0 (Isotonic Solutions) RN - 362O9ITL9D (Acetaminophen) RN - 68073-09-6 (normosol R) RN - 7LXU5N7ZO5 (Furosemide) RN - 8GTS82S83M (Diphenhydramine) RN - WI4X0X7BPJ (Hydrocortisone) RN - YOW8V9698H (Dimethyl Sulfoxide) SB - IM MH - Acetaminophen/therapeutic use MH - Adolescent MH - Adult MH - Aged MH - Blood Preservation/instrumentation/methods MH - Child MH - Child, Preschool MH - Cryopreservation MH - Cryoprotective Agents/adverse effects MH - Dimethyl Sulfoxide/adverse effects MH - Diphenhydramine/therapeutic use MH - Flushing/*etiology MH - Furosemide/therapeutic use MH - Hematologic Neoplasms/surgery MH - Humans MH - Hydrocortisone/therapeutic use MH - Hypertension/*etiology MH - Infant MH - Infant, Newborn MH - Infusions, Intravenous/*adverse effects/methods MH - Isotonic Solutions/adverse effects MH - Middle Aged MH - Nausea/*etiology MH - Neutrophils/immunology/transplantation MH - Peripheral Blood Stem Cell Transplantation/*adverse effects/methods MH - Premedication MH - Retrospective Studies MH - Risk Factors MH - Syringes MH - Young Adult EDAT- 2014/04/05 06:00 MHDA- 2014/10/15 06:00 CRDT- 2014/04/05 06:00 PHST- 2013/06/18 00:00 [received] PHST- 2013/12/10 00:00 [revised] PHST- 2013/12/12 00:00 [accepted] PHST- 2014/04/05 06:00 [entrez] PHST- 2014/04/05 06:00 [pubmed] PHST- 2014/10/15 06:00 [medline] AID - 10.1111/trf.12572 [doi] PST - ppublish SO - Transfusion. 2014 Aug;54(8):1997-2003; quiz 1996. doi: 10.1111/trf.12572. Epub 2014 Feb 17.